Literature DB >> 7561339

Immunology of Theiler's murine encephalomyelitis virus infection.

E L Oleszak1, J Kuzmak, R A Good, C D Platsoucas.   

Abstract

Theiler's murine encephalomyelitis virus (TMEV) is a single-stranded RNA virus that belongs to the family of picornaviruses. Intracranial inoculation of susceptible mouse strains with TMEV results in biphasic disease, consisting of early acute disease that resembles poliomyelitis, followed by late chronic demyelinating disease that is characterized by the appearance of chronic inflammatory demyelinating lesions. Susceptibility to TMEV infection is genetically controlled by three loci: one that maps to the H-2D region of the major histocompatibility complex, one to the beta-chain constant region of the T-cell antigen receptor, and one located on chromosome 3. Both early acute and chronic late demyelinating diseases are immunologically mediated. T cells appear to play an important role in the pathogenesis of the disease. TMEV-induced demyelinating disease in mice has extensive similarities with multiple sclerosis, and it is considered one of the best experimental animal models for multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561339     DOI: 10.1007/BF02918495

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  150 in total

1.  Theiler's virus replication in brain macrophages cultured in vitro.

Authors:  M Levy; C Aubert; M Brahic
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

2.  The role of CD8+T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice.

Authors:  P Borrow; P Tonks; C J Welsh; A A Nash
Journal:  J Gen Virol       Date:  1992-07       Impact factor: 3.891

3.  BALB/c substrain differences in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Authors:  S M Nicholson; J D Peterson; S D Miller; K Wang; M C Dal Canto; R W Melvold
Journal:  J Neuroimmunol       Date:  1994-06       Impact factor: 3.478

4.  Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin.

Authors:  M Rodriguez; A J Dunkel; R L Thiemann; J Leibowitz; M Zijlstra; R Jaenisch
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

5.  An isoelectric focusing overlay study of the humoral immune response in Theiler's virus demyelinating disease.

Authors:  R P Roos; E A Nalefski; S Nitayaphan; R Variakojis; K K Singh
Journal:  J Neuroimmunol       Date:  1987-01       Impact factor: 3.478

6.  Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus.

Authors:  J D Peterson; W J Karpus; R J Clatch; S D Miller
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

7.  Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis.

Authors:  P T Massa; V ter Meulen; A Fontana
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

8.  Cellular immunity in chronic Theiler's virus central nervous system infection.

Authors:  S G Rabinowitz; H L Lipton
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

9.  Study of the mechanisms by which CD4+ T cells contribute to protection in Theiler's murine encephalomyelitis.

Authors:  P Borrow; C J Welsh; A A Nash
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

10.  Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus.

Authors:  A Zurbriggen; J M Hogle; R S Fujinami
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  Oligoclonal T cells are infiltrating the brains of children with AIDS: sequence analysis reveals high proportions of identical beta-chain T-cell receptor transcripts.

Authors:  W L Lin; J E Fincke; L R Sharer; D S Monos; S Lu; J Gaughan; C D Platsoucas; E L Oleszak
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

3.  Inducible nitric oxide synthase in Theiler's murine encephalomyelitis virus infection.

Authors:  E L Oleszak; C D Katsetos; J Kuzmak; A Varadhachary
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

4.  Association between susceptibility to Theiler's virus-induced demyelination and T-cell receptor Jbeta1-Cbeta1 polymorphism rather than Vbeta deletion.

Authors:  Y Y Bahk; C A Kappel; G Rasmussen; B S Kim
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

5.  Chemokine expression in the central nervous system of mice with a viral disease resembling multiple sclerosis: roles of CD4+ and CD8+ T cells and viral persistence.

Authors:  R M Ransohoff; T Wei; K D Pavelko; J-C Lee; P D Murray; M Rodriguez
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 6.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

7.  Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis.

Authors:  E L Oleszak; E Zaczynska; M Bhattacharjee; C Butunoi; A Legido; C D Katsetos
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

8.  Genetic and immunological contributors to virus-induced paralysis.

Authors:  Aracely A Perez Gomez; Moumita Karmakar; Raymond J Carroll; Koedi S Lawley; Katia Amstalden; Colin R Young; David W Threadgill; C Jane Welsh; Candice Brinkmeyer-Langford
Journal:  Brain Behav Immun Health       Date:  2021-11-26

9.  Investigation of the role of delayed-type-hypersensitivity responses to myelin in the pathogenesis of Theiler's virus-induced demyelinating disease.

Authors:  P Borrow; C J Welsh; P Tonks; D Dean; W F Blakemore; A A Nash
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

Review 10.  Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014-2019.

Authors:  Bridget Martinez; Philip V Peplow
Journal:  Neural Regen Res       Date:  2020-07       Impact factor: 5.135

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.